![Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining in human liver and tonsil tissues . Corresponding HSD17B13 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/HSD17B13-Antibody-Immunohistochemistry-Paraffin-NBP1-90669-img0012.jpg "Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining in human liver and tonsil tissues . Corresponding HSD17B13 RNA-seq data are presented for the same tissues.")
| Reactivity | HuSpecies Glossary |
| Applications | ICC/IF, IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Immunogen | This antibody was developed against Recombinant Protein corresponding to amino acids: NNAGTVYPADLLSTKDEEITKTFEVNILGHFWITKALLPSMMERNHGHIVTVASVCGHEGIPYLIPYCSSKFAAVGFHRGLTSELQALGKTGIKTSCLCPVFVNTGFTKNPSTRLWPVLETDEVVRSLI |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | HSD17B13 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
||
| Application Notes | For IHC-Paraffin, HIER pH 6 retrieval is recommended. ICC/IF Fixation Permeabilization: Use PFA/Triton X-100. |
||
| Control Peptide |
|
||
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.2) and 40% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Purity | Immunogen affinity purified |
![Immunocytochemistry Granzyme A Antibody [Unconjugated]](https://images.novusbio.com/images2/Granzyme_A_AF2905_Immunocytochemistry_10939.jpg)
![ELISA Granzyme A Antibody [Unconjugated]](https://images.novusbio.com/images2/Granzyme_A_AF2905_ELISA_22249.jpg)
![Western Blot Granzyme A Antibody [Unconjugated]](https://images.novusbio.com/images2/Granzyme_A_AF2905_Western_Blot_23415.jpg)
| Publication using NBP1-90669 | Applications | Species |
|---|---|---|
| Frietze KK, Brown AM, Das D et al. Lipotoxicity reduces DDX58/Rig-1 expression and activity leading to impaired autophagy and cell death Autophagy 2021-05-09 [PMID: 33966599] |
Secondary Antibodies |
Isotype Controls |
Research Areas for HSD17B13 Antibody (NBP1-90669)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | HSD17B13 |
![Immunocytochemistry/Immunofluorescence: HSD17B13 Antibody [NBP1-90669] - Staining of human cell line U-251 MG shows localization to the Golgi apparatus and vesicles. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/HSD17B13-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-90669-img0013.jpg "Immunocytochemistry/Immunofluorescence: HSD17B13 Antibody [NBP1-90669] - Staining of human cell line U-251 MG shows localization to the Golgi apparatus and vesicles. Antibody staining is shown in green.")
![Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human placenta shows no positivity in trohphoblastic cells as expected.](http://images.novusbio.com/fullsize/HSD17B13-Antibody-Immunohistochemistry-Paraffin-NBP1-90669-img0014.jpg "Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human placenta shows no positivity in trohphoblastic cells as expected.")
![Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human liver shows moderate to strong granular cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/HSD17B13-Antibody-Immunohistochemistry-Paraffin-NBP1-90669-img0009.jpg "Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human liver shows moderate to strong granular cytoplasmic positivity in hepatocytes.")
![Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human skin shows moderate granular cytoplasmic positivity in basal epidermal cells.](http://images.novusbio.com/fullsize/HSD17B13-Antibody-Immunohistochemistry-Paraffin-NBP1-90669-img0010.jpg "Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human skin shows moderate granular cytoplasmic positivity in basal epidermal cells.")
![Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human tonsil shows no positivity in lymphoid cells as expected.](http://images.novusbio.com/fullsize/HSD17B13-Antibody-Immunohistochemistry-Paraffin-NBP1-90669-img0011.jpg "Immunohistochemistry-Paraffin: HSD17B13 Antibody [NBP1-90669] - Staining of human tonsil shows no positivity in lymphoid cells as expected.")
![Western Blot Annexin A7 Antibody [Unconjugated]](https://images.novusbio.com/images2/Annexin_A7_AF3926_Western_Blot_5364.jpg)
![Simple Western Annexin A7 Antibody [Unconjugated]](https://images.novusbio.com/images/antibody/af3926_human-mouse-rat-annexin-a7-affinity-purified-polyclonal-ab-simple-western-7112024125536..jpg)
![Bioactivity IL-4 [Unconjugated]](https://images.novusbio.com/images/protein/6507-ilcf_recombinant-human-il-4-cho-expressed-protein-cf-bioactivity-272020133214.jpg)
![Western Blot Androgen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) - BSA Free](https://images.novusbio.com/images/Androgen-R-NR3C4-p-Ser213-p-Ser210-Antibody-156C135-2-Western-Blot-NB100-56603-img0004.jpg)
![Western Blot alpha 1-Acid Glycoprotein Antibody (386131) [Unconjugated]](https://images.novusbio.com/images2/alpha_1-Acid_Glycoprotein_MAB3694_Western_Blot_6125.jpg)
![Western Blot alpha 1-Acid Glycoprotein Antibody (386131) [Unconjugated]](https://images.novusbio.com/images2/alpha_1Acid_Glycoprotein_MAB3694_Western_Blot_21887.jpg)
![Immunohistochemistry alpha 1-Acid Glycoprotein Antibody (386131) [Unconjugated]](https://images.novusbio.com/images2/alpha_1-Acid_Glycoprotein_MAB3694_Immunohistochemistry_9988.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")